Avara Pharmaceutical Services Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

 


Get this Report



PayPal Verified Vendor

Rating

4.1 Star Rating for report Avara Pharmaceutical Services Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
4.1 / 5 stars rating
Pages: 18
Price: $250.00

Some of our Clients

Some Research and Expert Clients

Abstract

 
Avara Pharmaceutical Services Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
 

Description

Avara Pharmaceutical Services Inc (Avara) is a contract development and manufacturing organization that provides primary formulation and manufacturing, secondary manufacturing and packaging of small molecules. It offers wide range of services such as manufacturing of active pharmaceutical ingredients (API), packaging, process scale-up and optimization and multi-purpose equipment and facility designs, and blending among others. Avara spans its expertise in tablet printing, capsule filling, fluid bed granulation, spray drying, product release testing, stability storage and testing and CTM packaging in bottles and blisters. The company caters its services to the pharmaceutical industry. Avara is located in Norwalk, Connecticut, the US. 

Report Source Information

Supplied by: Research and Experts 
Date Published: 2017-11-27 

Report: Avara Pharmaceutical Services Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

 

Contents

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Avara Pharmaceutical Services Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Avara Pharmaceutical Services Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Avara Pharmaceutical Services Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Avara Pharmaceutical Services Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Avara Pharmaceutical Services Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Avara Pharmaceutical Services Inc, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Avara Pharma Acquires Reims Manufacturing Facility from AstraZeneca 10
Avara Pharma to Acquire Consumer Healthcare Manufacturing Facility from GlaxoSmithKline 11
Avara Pharma to Acquire Sterile Manufacturing from Pfizer 12
Avara Pharma Acquires Manufacturing Facility from AstraZeneca 13
Acquisition 14
Avara Pharma Acquires Astellas Pharma Technologies from Astellas US Holding 14
Avara Pharmaceutical Services Inc - Key Competitors 15
Avara Pharmaceutical Services Inc - Key Employees 16
Avara Pharmaceutical Services Inc - Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18
 

List of Tables

List of Tables
Avara Pharmaceutical Services Inc, Pharmaceuticals & Healthcare, Key Facts 2
Avara Pharmaceutical Services Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Avara Pharmaceutical Services Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Avara Pharmaceutical Services Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Avara Pharmaceutical Services Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Avara Pharmaceutical Services Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Avara Pharma Acquires Reims Manufacturing Facility from AstraZeneca 10
Avara Pharma to Acquire Consumer Healthcare Manufacturing Facility from GlaxoSmithKline 11
Avara Pharma to Acquire Sterile Manufacturing from Pfizer 12
Avara Pharma Acquires Manufacturing Facility from AstraZeneca 13
Avara Pharma Acquires Astellas Pharma Technologies from Astellas US Holding 14
Avara Pharmaceutical Services Inc, Key Competitors 15
Avara Pharmaceutical Services Inc, Key Employees 16
Avara Pharmaceutical Services Inc, Other Locations 17
Avara Pharmaceutical Services Inc, Subsidiaries 17
 

List of Figures

List of Figures
Avara Pharmaceutical Services Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 2
Avara Pharmaceutical Services Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 2
Avara Pharmaceutical Services Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 2
Avara Pharmaceutical Services Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 2
Avara Pharmaceutical Services Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Avara Pharmaceutical Services Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Avara Pharmaceutical Services Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Avara Pharmaceutical Services Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
 

Scope


- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

 

Classification

Language Code: EN 
Region: United States 
Report Type: Company Reports 
Industry: Life Sciences 
Sector: Life Sciences 
Pages: 18 

Reasons to buy this report

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
 

Avara Pharmaceutical Services Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Report 05IC-GDPH2548182D has a rating of 82 percent
Figure of merit assessment for report 05IC-GDPH2548182D

Relevance Rating

The Research and Experts relevance ranting consists of a set of figure of merit (FOM) values that are provided as an indication of the value of the report in the current economic environment.

These FOM values cannot take into account the reason for the clients interest in a report and therefore the client should view these FOM values only as a visual guide. The FOM scores are based on

market interest - how often the report is viewed or purchased,
elapsed time - time since the report was published,
report detail - amount of detail in the report (pages, figures, images, comments etc.) and
price - the price of the report.


Regional Information

Taxonomy

Branch ID: 1555

Taxonomy Location

The taxonomy on the left shows the ancestors of the United States node. This provides an insight into parent categories that may provide reports or articles that may compliment this report. The number in brackets after the node name indicates the number of reports that Research and Experts currently have in the parent category.

Clicking on a parent category will present the list of reports in the parent node in a separate window.

United States

The US has the largest economy in the world. It is highly industrialised and some of the main industries include; petroleum, steel, motor vehicles, aerospace, telecommunications, chemicals, electronics, food processing, consumer goods, lumber and mining.  

The US economy is dealing with slow growth rates, unemployment and increasing national debt since the recession of 2008/2009 however economists expect much higher growth in the US economy in 2014. The IMF expects growth to increase from 1.9% in 2013 to 2.8% in 2014.  The IMF expects a drop in unemployment to 6% in 2014. The indicators are good. The private sector is growing, federal spending will continue and some of the underlying drags on the economy are diminishing. Cheaper energy coming from increased oil exploration, gas fracking and renewables has helped to bring more jobs back to the US. The manufacturing sector is growing again and manufacturing technology is improving. 

There is a shortage of housing as a result of limited construction in recent years. Satisfying this demand should provide a much needed boost for the construction industry. There has also been considerable under investment in many other areas of the economy during the credit crunch and it is expected that there will be growth in the IT sector as companies carry out much needed upgrading of systems. 

Inequality is a major issue in the US economy. More of the wealth is going to the top 1% of high earners and middle incomes are stagnant. Tax reform is necessary for the redistribution of wealth. By putting more money in the pockets of the lower and middle classes the US economy will start to see some real growth.

Researchandexperts.com is a leading source of market research on key industry sectors in the USA.

Useful Links

World Bank Overview of the United States

CIA World Factbook on the United States

The International Monetary Fund on the US Economy

United States

Northern America

Region

 

North America

The term North America usually refers to the US and Canada sometimes including Geenland, Mexico and the islands of Bermuda, St Helena and Saint Pierre et Miquelon.  

North America is dominated by the largest global economy, the United States. The main industries in the US are technology, petroleum, steel, motor vehicles, aerospace, telecommunications, chemicals, electronics, food processing, consumer goods, lumber and mining. The US main tading partners are Canada, China, Mexico, Japan, and Germany. Canada is one of the largest economies in the world and is listed as one of the G8. Canada has a well established services sector along with well established industries in the areas of maufacturing, mining and logging. Canada's main trading partners are US, EU, China and Mexico.

 Research and Experts, the market intelligence platform, provides companies with access to the latest leading industry reports covering the North American region. Our company reports contain the following information; company overviews, key facts, key employees, products and services, as well as financial ratios. Our industry reports are vital sources of detailed historic and forecast values for markets in North America, segmented at category level.

Research and Experts reports also provide regional analysis and analysis of the leading companies in key North American markets.  Researchandexperts.com is a  leading source of market research on North America.

North America

Country

Countries

 

Industry Sector Information

Taxonomy

Branch ID: 205

Taxonomy Location

The taxonomy on the left shows the ancestors of the Life Sciences node. This provides an insight into parent categories that may provide reports or articles that may compliment this report. The number in brackets after the node name indicates the number of reports that Research and Experts currently have in the parent category.

Clicking on a parent category will present the list of reports in the parent node in a separate window.

Life Sciences

The Life Sciences industry includes biotechnology, healthcare, pharmaceuticals, medical devices and diagnostics. The industry is dominated by US companies requiring considerable investment in research and development to stay competitive.  While US companies dominate this space, competition is emerging from smaller companies in Europe and Asia. 

Companies trying to stay competitive or enter new markets in life sciences consult our reports. For example, Plimsoll, in their recent review of global antibiotic manufacturers have reviewed 150 of the largest manufacturers including analysis of  ANTIBIOTICE SA, BAYER HEALTHCARE MANUFACTURING SRL and CIPLA LTD. 

Our reports are a requirement for companies looking for the best competitive intelligence in the life sciences sector providing information on market size, rankings, best trading partners and financial analysis. 

Useful Links

Analytical Life Sciences and Diagnostics Association

German Life Sciences Association

 

Life Sciences

Industry

Industries

 

 

Buy: Avara Pharmaceutical Services Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

 

Item Code: 05IC-GDPH2548182D

 
Licence: Single User
Price: $250.00
 
VAT: 0.0% 
Total: $250.00 

Feedback

Return to Research and Experts

Page created and rendered - Cache updated [0.25928s]

--